Searched for
SUN PHARMA FUNDRAISING
Sun Pharma falls short of bond fundraising target amid rising yieldsSun Pharma successfully secured ₹7,816 crore in its latest fundraising round, yet it fell short of its ambitious ₹10,000-crore target. The ...- Sun Pharma to raise Rs 10,000 crore to part-finance Organon dealSun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance b...
- Stocks in news: Reliance Industries, Eternal, IREDA, Yes Bank, Trent and Hindustan ZincIndian equity benchmarks experienced a decline as profit-booking occurred amid rising crude oil prices. The Nifty 50 dropped significantly,...
- Ahead of Market: 10 things that will decide stock market action on WednesdayNifty’s indicative price plunged 2% in two seconds during the closing auction session on monthly expiry, before recovering sharply. Analyst...
- Why is market falling today? War woes, oil spike and 4 other factors behind Rs 5 lakh cr D-Street routIndian stock markets tumbled significantly on Friday, with benchmark indices Sensex and Nifty recording considerable dips. The sharp surge ...
- Pharma deal activity hits four-quarter low, but mega Sun Pharma acquisition drives valueIndia's pharma and healthcare sector recorded 65 deals worth $13.9 billion in Q2 CY2026, with volumes falling 17% quarter-on-quarter to a f...
- Stocks in news: SBI, BSE, Anand Rathi Share, Tata Steel, PFC, Kotak Mahindra BankMarkets remained range-bound, ending flat as consolidation continues with a positive bias above 25,400 for Nifty. SBI reported a 24% YoY ne...
- Sudeep Pharma IPO: Mukul Agrawal, Prashant Jain among investors in Rs 268 crore anchor bookSudeep Pharma secured strong anchor investor participation ahead of its IPO, attracting major mutual funds, insurers and marquee investors,...
- Pharma stocks in focus as Trump signals tariffs on imported medicinesPresident Trump announced potential tariffs on imported pharmaceuticals, impacting countries like India, a major supplier to the US drug ma...
- Global private equity funds in talks to purchase minority stake in BDR PharmaceuticalsFunds like the Carlyle Group, Warburg Pincus and TA Associates are engaged in initial discussions, the people added. Investment bank O3 Cap...
- Two largecap pharma stocks for long-term investors"There are good expectations from the pharma basket in the run-up to the results."
- Valuation never a concern for SBI, it still trades under book: Chakri Lokapriya‘The moratorium, which has been a niggling issue in the minds of investors, is turning out to be better than expected.’
- Stocks in the news: YES Bank, Simplex Infra, ITI, D-Mart, Sun Pharma and Hero MotoCorpITI withdrew its follow-on public offer citing "prevailing market conditions".
- Firm on pharma, Dilip Shanghvi surrenders NBFC licenceRBI puts on hold Shanghvi Finance's request for core investment company licence.
- Sun Pharmaceuticals to set up an ethics committee to oversee corporate governance-related mattersSudhir Valia to focus more on pursuits outside Sun, but continues to be a valuable resource for the company.
- Sun promoters pledged firm's shares for SurakshaShanghvi's brother-in-law and realty co owner Valia denies drugmaker stood guarantee for fundraising.
- Stocks in the news: L&T, Sun Pharma, Kotak Mahindra Bank, Mindtree, Wipro and HDFC BankHere are a few stocks which may buzz the most in today's trade.
- Any relaxation of foreign investment norms is a big positive: SL Narayanan, Sun Group"It is indicative of the mood of the government that they want to open up."
- Government plans implementing National Framework for Malaria Elimination with Sun PharmaThe public-private partnership agreement is likely to be signed next week and will add funds to the National Framework for Malaria Eliminat...
- Sun Pharma Laboratories to raise Rs 2,800 crore from banks: ICRADespite acquisitions, this year has been tough for Sun as the company has been battling quality issues in its own manufacturing facilities.
Load More
